INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 216 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $174 | -93.1% | 212 | -86.9% | 0.00% | – |
| Q4 2022 | $2,521 | +152.1% | 1,616 | +233.9% | 0.00% | – |
| Q3 2022 | $1,000 | -80.0% | 484 | -68.2% | 0.00% | – |
| Q1 2022 | $5,000 | +150.0% | 1,522 | +234.5% | 0.00% | – |
| Q4 2021 | $2,000 | -88.2% | 455 | -80.8% | 0.00% | -100.0% |
| Q3 2021 | $17,000 | -34.6% | 2,373 | -16.6% | 0.00% | 0.0% |
| Q2 2021 | $26,000 | +1200.0% | 2,847 | +1438.9% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 185 | +164.3% | 0.00% | – |
| Q4 2020 | $1,000 | – | 70 | -93.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 1,000 | -60.0% | 0.00% | -100.0% |
| Q2 2014 | $27,000 | – | 2,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |